Published in Am J Hum Genet on July 01, 1996
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study. Lancet (2008) 7.05
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am J Hum Genet (2001) 6.56
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol (2002) 6.20
Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density. Am J Hum Genet (2003) 2.86
Genetics of osteoporosis from genome-wide association studies: advances and challenges. Nat Rev Genet (2012) 2.07
Update on Wnt signaling in bone cell biology and bone disease. Gene (2011) 2.03
Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13) Am J Hum Genet (1997) 1.75
Clinical and molecular findings in osteoporosis-pseudoglioma syndrome. Am J Hum Genet (2005) 1.52
Osteoarthritis-susceptibility locus on chromosome 11q, detected by linkage. Am J Hum Genet (1999) 1.27
Syndromes with congenital brittle bones. BMC Pediatr (2004) 1.12
Basic and clinical aspects of osteoporosis in inflammatory bowel disease. World J Gastroenterol (2007) 1.12
Regulation of Wnt/β-catenin signaling within and from osteocytes. Bone (2013) 1.08
Searching for osteoporosis genes in the post-genome era: progress and challenges. Osteoporos Int (2003) 1.05
LRP5 and LRP6 are not required for protective antigen-mediated internalization or lethality of anthrax lethal toxin. PLoS Pathog (2007) 1.05
A genome-wide linkage scan for bone mineral density in an extended sample: evidence for linkage on 11q23 and Xq27. J Med Genet (2004) 1.00
The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcif Tissue Int (2007) 1.00
Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG). Eur J Hum Genet (2011) 0.97
Association between LRP5 polymorphism and bone mineral density: a Bayesian meta-analysis. BMC Med Genet (2008) 0.96
Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci (Landmark Ed) (2014) 0.94
A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice. Bone Res (2013) 0.94
cDNA cloning and characterization of human Delta5-desaturase involved in the biosynthesis of arachidonic acid. Biochem J (2000) 0.91
SOST and DKK: Antagonists of LRP Family Signaling as Targets for Treating Bone Disease. J Osteoporos (2010) 0.91
Lrp5 is not required for the proliferative response of osteoblasts to strain but regulates proliferation and apoptosis in a cell autonomous manner. PLoS One (2012) 0.86
Silencing Dkk1 expression rescues dexamethasone-induced suppression of primary human osteoblast differentiation. BMC Musculoskelet Disord (2010) 0.85
LRP5 and bone mass regulation: Where are we now? Bonekey Rep (2012) 0.83
Embryonic ablation of osteoblast Smad4 interrupts matrix synthesis in response to canonical Wnt signaling and causes an osteogenesis-imperfecta-like phenotype. J Cell Sci (2013) 0.83
Fibulin-4 regulates expression of the tropoelastin gene and consequent elastic-fibre formation by human fibroblasts. Biochem J (2009) 0.80
Modifying Role of GSTP1 Polymorphism on the Association between Tea Fluoride Exposure and the Brick-Tea Type Fluorosis. PLoS One (2015) 0.80
The effect of antiresorptives on bone quality. Clin Orthop Relat Res (2011) 0.79
LRP receptor family member associated bone disease. Rev Endocr Metab Disord (2015) 0.78
HIV-1 protein induced modulation of primary human osteoblast differentiation and function via a Wnt/β-catenin-dependent mechanism. J Orthop Res (2012) 0.78
Searching for gene defects that cause high bone mass. Am J Hum Genet (1997) 0.78
The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment. Ital J Pediatr (2014) 0.77
How genomics has informed our understanding of the pathogenesis of osteoporosis. Genome Med (2009) 0.77
Replication study of three functional polymorphisms associated with bone mineral density in a cohort of Spanish women. J Bone Miner Metab (2013) 0.76
Osteogenesis imperfecta and primary open angle glaucoma: genotypic analysis of a new phenotypic association. Mol Vis (2014) 0.76
Relevance of Wnt signaling for osteoanabolic therapy. Mol Cell Ther (2014) 0.75
Critical Endothelial Regulation by LRP5 during Retinal Vascular Development. PLoS One (2016) 0.75
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling. Mol Neurodegener (2017) 0.75
Value of rare low bone mass diseases for osteoporosis genetics. Bonekey Rep (2016) 0.75
How rare bone diseases have informed our knowledge of complex diseases. Bonekey Rep (2016) 0.75
Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5. Case Rep Genet (2016) 0.75
Clinical and biochemical response to neridronate treatment in a patient with osteoporosis-pseudoglioma syndrome (OPPG). Osteoporos Int (2017) 0.75
Genetic mapping of the galanin-GMAP (Galn) gene to mouse chromosome 19. Mamm Genome (1998) 0.75
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet (1985) 87.59
Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A (1989) 18.26
Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science (1987) 12.20
Improved double-stranded DNA sequencing using the linear polymerase chain reaction. Nucleic Acids Res (1989) 5.53
Prediction of bone density from vitamin D receptor alleles. Nature (1994) 5.36
Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med (1995) 5.27
A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat Genet (1994) 3.70
Bardet-Biedl syndrome is linked to DNA markers on chromosome 11q and is genetically heterogeneous. Nat Genet (1994) 2.26
Assignment of a locus for dominantly inherited venous malformations to chromosome 9p. Hum Mol Genet (1994) 1.83
The ocular form of osteogenesis imperfecta: a new autosomal recessive syndrome. Clin Genet (1985) 1.27
Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J Bone Miner Res (1995) 1.27
Genetic linkage of autosomal dominant neovascular inflammatory vitreoretinopathy to chromosome 11q13. Hum Mol Genet (1992) 1.22
The autosomal dominant familial exudative vitreoretinopathy locus maps on 11q and is closely linked to D11S533. Am J Hum Genet (1992) 1.22
Osteoporosis-pseudoglioma syndrome: report of three affected sibs and an overview. Am J Med Genet (1985) 1.08
Osteoporosis-pseudoglioma or osteogenesis imperfecta? Clin Genet (1986) 1.04
Relations between age, mineral density and mechanical properties of human femoral compacta. Acta Orthop Scand (1976) 1.03
Osteoporosis-pseudoglioma syndrome. Am J Med Genet (1993) 1.00
Osteoporosis-pseudoglioma syndrome: clinical, morphological, and biochemical studies. J Med Genet (1988) 0.98
cDNA cloning and chromosomal localization of the human beta-adrenergic receptor kinase. FEBS Lett (1991) 0.96
Report of the fourth international workshop on human chromosome 11 mapping 1994. Cytogenet Cell Genet (1995) 0.93
Osteosclerosis, a recessive skeletal mutation on chromosome 19 in the mouse. J Hered (1985) 0.92
Structural organization of the genes encoding human and murine FK506-binding protein (FKBP) 13 and comparison to FKBP1. Gene (1993) 0.90
[Hyaloid-retinal dysplasia (pseudoglioma) due to recessive autosomal heredity]. Ann Ocul (Paris) (1969) 0.89
[Hyaloretinal degeneration with osteoporosis and bone fragility. Pseudoglioma with bone fragility (author's transl)]. J Radiol (1981) 0.89
Refining the locus for Best vitelliform macular dystrophy and mutation analysis of the candidate gene ROM1. Am J Hum Genet (1994) 0.87
The osteoporosis pseudoglioma syndrome. Update and report on two affected siblings. Pediatr Radiol (1988) 0.86
Assignment of the beta-arrestin 1 gene (ARRB1) to human chromosome 11q13. Genomics (1994) 0.83
Osteochondrodystrophy (ocd): a new autosomal recessive mutation in the mouse. J Hered (1991) 0.83
Dinucleotide repeat polymorphism at the PPP1CA locus on 11q13. Hum Mol Genet (1994) 0.81
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Hybridization of synthetic oligodeoxyribonucleotides to phi chi 174 DNA: the effect of single base pair mismatch. Nucleic Acids Res (1979) 14.12
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell (1997) 13.53
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell (2001) 11.99
Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol Cell (1998) 9.85
The use of synthetic oligonucleotides as hybridization probes. II. Hybridization of oligonucleotides of mixed sequence to rabbit beta-globin DNA. Nucleic Acids Res (1981) 9.56
Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin. Science (1977) 9.28
fw2.2: a quantitative trait locus key to the evolution of tomato fruit size. Science (2000) 7.91
Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet (1998) 7.68
Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med (2000) 7.61
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell (1994) 7.39
Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin. Proc Natl Acad Sci U S A (1981) 7.24
Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques (2000) 7.03
Articular mobility in an African population. Ann Rheum Dis (1973) 7.01
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet (2001) 6.96
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet (1997) 6.85
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature (1987) 6.66
Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature (2001) 6.36
Chemical synthesis of genes for human insulin. Proc Natl Acad Sci U S A (1978) 6.09
Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature (1989) 6.07
Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science (1999) 6.02
Digital tomosynthesis in breast imaging. Radiology (1997) 5.82
Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A (1997) 5.76
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med (2001) 5.68
Separation of caveolae from associated microdomains of GPI-anchored proteins. Science (1995) 5.25
Altered growth and branching patterns in synpolydactyly caused by mutations in HOXD13. Science (1996) 5.13
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell (1996) 5.10
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat Genet (2001) 5.09
High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod (1993) 5.06
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet (2001) 4.97
Comparing sequenced segments of the tomato and Arabidopsis genomes: large-scale duplication followed by selective gene loss creates a network of synteny. Proc Natl Acad Sci U S A (2000) 4.90
Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell (1999) 4.87
Expression in Escherichia coli of chemically synthesized genes for human insulin. Proc Natl Acad Sci U S A (1979) 4.72
Structural homology of Torpedo californica acetylcholine receptor subunits. Nature (1983) 4.70
Primary structure and functional expression from complementary DNA of the rod photoreceptor cyclic GMP-gated channel. Nature (1989) 4.55
A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. Nature (2010) 4.52
Genome sequence, comparative analysis, and population genetics of the domestic horse. Science (2009) 4.41
Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat Cell Biol (2001) 4.38
Imprint switching on human chromosome 15 may involve alternative transcripts of the SNRPN gene. Nat Genet (1996) 4.36
Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell (1993) 4.13
Efficient correction of a mutation by use of chemically synthesized DNA. Proc Natl Acad Sci U S A (1978) 4.13
Predicting disease genes using protein-protein interactions. J Med Genet (2006) 4.10
The modular nature of genetic diseases. Clin Genet (2007) 4.06
Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (1996) 3.99
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet (2009) 3.87
Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet (2000) 3.87
In vitro and in vivo activity of NY-198, a new difluorinated quinolone. Antimicrob Agents Chemother (1987) 3.84
Ultralong single-wall carbon nanotubes. Nat Mater (2004) 3.83
Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci U S A (1996) 3.83
Two improved methods for preparing ferritin-protein conjugates for electron microscopy. J Cell Biol (1975) 3.81
Detection and characterisation of an overmodified type III collagen by analysis of non-cutaneous connective tissues in a patient with Ehlers-Danlos syndrome IV. J Med Genet (1992) 3.80
Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature (1995) 3.78
Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports. J Med Genet (2006) 3.70
Primary structure of alpha-subunit precursor of Torpedo californica acetylcholine receptor deduced from cDNA sequence. Nature (1982) 3.69
A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell (1995) 3.59
A prognostic score for patients with lower risk myelodysplastic syndrome. Leukemia (2007) 3.45
CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry (2007) 3.44
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet (2000) 3.39
Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int (2016) 3.30
Orthopaedic aspects of the Ehlers-Danlos syndrome. J Bone Joint Surg Br (1969) 3.30
Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care (2001) 3.27
A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature (1989) 3.27
Genetic analysis of salt tolerance in arabidopsis. Evidence for a critical role of potassium nutrition. Plant Cell (1998) 3.25
The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science (1999) 3.23
Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet (1998) 3.18
The major facilitator superfamily. J Mol Microbiol Biotechnol (1999) 3.17
Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature (1982) 3.09
An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3. J Cell Biol (1998) 3.04
Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care (1997) 3.03
CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene. J Med Genet (2005) 3.03
Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem (1996) 3.01
Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys (1998) 2.99
Acupuncture modulates the limbic system and subcortical gray structures of the human brain: evidence from fMRI studies in normal subjects. Hum Brain Mapp (2000) 2.98
Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol (1999) 2.95
Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63. Hum Mol Genet (2001) 2.95
A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res (2000) 2.94
Genetic architecture of a morphological shape difference between two Drosophila species. Genetics (2000) 2.92
New tumor markers: CA125 and beyond. Int J Gynecol Cancer (2005) 2.92
Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet (2007) 2.91